Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In the SURPASS trials, all participants had type 2 diabetes
Thyroid 32 (11), 14111422
Lawsuit claims Ozempic, Mounjaro labels downplayed severity of gastroparesis A personal injury law firm has filed a lawsuit against Novo Nordisk and Eli Lilly, alleging the manufacturers downplayed the severity of the gastrointestinal events caused by Ozempic and Mounjaro, such as gastroparesis and gastroenteritis
Real-world data from electronic health records tells a similar story, though the gap narrows somewhat in patients who also have type 2 diabetes
For people considering whether the timeline for tirzepatide to work fits their goals, the answer is usually encouraging
That means we take the time to understand your specific needs, medical history, and goals before creating an effective and healthy weight loss program
